Hernia mesh claims: who can file and what to do in Pennsylvania

Pennsylvania hernia mesh plaintiffs fall under the same multi-MDL structure: Davol/CR Bard MDL 2846 (S.D. Ohio, Judge Sargus) for Bard products; Covidien MDL 3029 (D. Mass.) for Medtronic/Covidien products; Atrium C-QUR MDL 2753 (D.N.H.); and the Atlantic County NJ Superior Court mass tort for Ethicon/J&J Physiomesh and Prolene claims before Judge Porto. Pennsylvania's Eastern and Western Districts serve as common originating venues before tag-along transfer to MDL.

Pennsylvania has a two-year statute of limitations for products liability under 42 Pa. C.S. § 5524. The discovery rule is well-established: the limitations period begins when the plaintiff knows or has reason to know of the injury and its relationship to the defendant's product. Pennsylvania courts have held that mesh complications that become symptomatic years after implantation — including bowel obstruction, erosion, and chronic neuropathic pain — support delayed discovery accrual.

Pennsylvania hosts significant hernia mesh implant activity through the University of Pennsylvania Health System, Jefferson Health, UPMC, and Geisinger. Philadelphia and Pittsburgh are the primary surgical hubs. Bard Davol's PerFix and Ventralex products and Covidien Parietex Composite mesh dominate defendant product distribution. Pennsylvania also has a history of early Atrium C-QUR claims from New Hampshire-adjacent Northeast markets.

Pennsylvania's proximity to Atlantic County, NJ gives Pennsylvania Ethicon plaintiffs a geographic advantage in the state court mass tort. The Atlantic County consolidation for J&J/Ethicon cases under Judge Porto is mandatory for plaintiffs pursuing J&J's New Jersey-registered corporate entity, and Pennsylvania counsel frequently practice in that forum via pro hac vice.